During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium (original) (raw)

References

1. Sasaki, A., Melder, R.J., Whiteside, T.L., Herberman, R.B. & Jain, R.K. referential localization of human adherent lymphokine-activated killer cells in tumor microcirculation. J. Natl. Cancer Inst. 53, 433–437 (1991).
   Article Google Scholar
2. Melder, R.J. et al. Imaging of activated natural killer (NK) cells in mice by positron emission tomography (PET): Preferential uptake in tumors. Cancer Res. 53, 5867–5871 (1993).
   CAS PubMed Google Scholar
3. Melder, R.J., Salehi, H.A. & Jain, R.K. Localization of activated natural killer cells in MCalV mammary carcinoma grown in cranial windows in C3H mice. Microvascular Res. 50, 35–44 (1995).
   Article CAS Google Scholar
4. Melder, R.J., Walker, E., Herberman, R.B. & Whiteside, T.L. dhesion characteristics of human interleukin 2-activated natural killer cells. Cell. Immunol. 132, 177–192 (1991).
   Article CAS Google Scholar
5. Allavena, P. et al. Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J. Exp. Med. 173, 439–448 (1991).
   Article CAS Google Scholar
6. Melder, R.J., Munn, L.L., Yamada, S., Ohkubo, C. & Jain, R.K. Selectin- and integrin-mediated T lymphocyte rolling and arrest on TNF-alpha-activated endothelium: Augmentation by erythrocytes. Biophys. J. 69, 2131–2138 (1995).
   Article CAS Google Scholar
7. Jain, R.K. et al. Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer Metastasis Rev. 15, 195ndash;204 (1996).
   Article CAS Google Scholar
8. Munn, L.L., Melder, R.J. & Jain, R.K. Analysis of cell flux in the parallel plate flow chamber: Implications for cell capture studies. Biophys.J. 67, 889–895 (1994).
   Article CAS Google Scholar
9. Munn, L.L., Koenig, G.C., Jain, R.K. & Melder, R.J. Kinetics of adhesion mole cule expression and spatial organization using targeted sampling fluorometry. BioTechniques 19, 622–631 (1995).
   CAS PubMed Google Scholar
10. Yuan, F. et al. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 54, 4564–4568 (1994).
    CAS PubMed Google Scholar
11. Jain, R.K. Determinants of tumor blood flow: A review. Cancer Res. 48, 2641 2648 (1988).
    CAS Google Scholar
12. de Fourgerolles, A.R., Stacker, S.A., Schwarting, R. & Springer, T.A. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. Exp.Med 174, 253–267 (1991).
    Article Google Scholar
13. Folkman, J. Tumor angiogenesis. in The Molecular Basis of Cancer (eds. Mendelson, J., Howley, P.M. & Liotta, L.A.) 206–232 (Saunders, Philadelphia, 1995).
    Google Scholar
14. Fidler, I.J. & Elis, L.M. The implications of angiogenesis for biology and therapy of cancer metastasis. Cell 79, 185–188 (1994).
    Article CAS Google Scholar
15. Jallal, B. et al. Suppression of tumor growth in vivo by local and systemic 90K level increase. Cancer Res. 55, 3223–3227 (1995).
    CAS PubMed Google Scholar
16. Dvorak, H.F., Brown, L.F., Detmar, M. & Dvorak, A.M. ascular permeability factorJvascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029–1039 (1995).
    CAS PubMed PubMed Central Google Scholar
17. Reed, J.A., McNutt, N.S. & Albino, A.P. Differential expression of basic FGF (bFGF) in melanocytic lesions demonstrated by in situ hybridization: Implications for tumor progression. Am. J. Pathol. 144, 329–336 (1994).
    CAS PubMed PubMed Central Google Scholar
18. Goto, F., Goto, K., Weidel, K. & Folkman, J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. J.Lab. Invest. 69, 508–517 (1993).
    CAS Google Scholar
19. Ferrara, N. Missing link in angiogenesis. Nature 376, 467 (1995).
    Article CAS Google Scholar
20. Koch, A.E., Halloran, M.M., Haskell, C.K., Shah, M.R. & PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376, 517–519 (1995).
    Article CAS Google Scholar
21. Friedlander, M. et al. Definition of two angiogenic pathways by distinct alpha vintegrins. Science 270, 1500–1502 (1995).
    Article CAS Google Scholar
22. Brooks, P.C. et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157–1164 (1994).
    Article CAS Google Scholar
23. Fukumura, D. et al. Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: Effect of tumor type, transplantation site, and host strain. Cancer Res. 55, 4824–4829 (1995).
    CAS PubMed Google Scholar
24. Ohkubo, C., Bigos, D. & Jain, R.K. IL-2 induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: Implications for vascular- leak syndrome. Cancer Res. 51, 1561 1563 (1991).
    CAS PubMed Google Scholar
25. Wu, N.Z., Klitzman, B., Dodge, R. & Dewhirst, M.W. iminished leukocyteendothelium interaction in tumor microvessels. Cancer Res. 52, 4265–4268 (1992).
    CAS PubMed Google Scholar
26. Osborn, L. Leukocyte adhesion to endothelium in inflammation. Cell 62, 3–6 (1990).
    Article CAS Google Scholar
27. Gamble, J.R., Khew-Goodall, Y. & Vadas, M.A. Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J. Immunol. 150, 4494 4503 (1993).
    CAS PubMed Google Scholar
28. Santambrogio, L. et al. Studies on the mechanisms by which transforming growth factor-beta protects against allergic encephalomyelitis. J. Immunol. 151, 1116–1127 (1993).
    CAS PubMed Google Scholar
29. Blotnick, S., Peoples, G.E., Freeman, M.R., Eberlein, T.J. & Klagsbrun, M. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: Differential production and release by CD4+ and CD8+ T cells. Proc. Natl. Acad. Sci. USA 91, 2890–2894 (1994).
    Article CAS Google Scholar
30. Freeman, M.R. et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Res. 55, 4140–4115 (1995).
    CAS PubMed Google Scholar
31. Dellian, M., Witwer, B.P., Salehi, H.A., Yuan, F. & Jain, R. uantitation and physiological characterization of angiogenic vessels in mice. Am. J. Pathol. 149, 59–71 (1996).
    CAS PubMed PubMed Central Google Scholar
32. Melder, R.J. & Jain, R.K. Kinetics of interleukin-2 induced changes in rigidity of human natural killer cells. Cell Biophys. 20, 161–176 (1992).
    Article CAS Google Scholar
33. Sasaki, A., Jain, R.K., Maghazachi, A.A., Goldfarb, R.H. & Herberman, R.B. Low deformability of lymphokine-activated killer cells as a possible determinant of in vivo distribution. Cancer Res. 49, 3742–3746 (1989).
    CAS PubMed Google Scholar
34. Whiteside, T.L. & Goldfarb, R.H. Antitumor effector cells: Extravasation and control of metastasis. Immunol. Ser. 61, 159–173 (1994).
    CAS PubMed Google Scholar
35. Melder, R.J. et al. Cytotoxic activity against HIV infected monocytes by recombinant interleukin 2-activated natural killer cells. AIDS Res. Hum. Retrovir. 6, 1011–1015 (1990).
    Article CAS Google Scholar
36. Kitayama, J. et al. Lysis of endothelial cells by autologous lymphokine-activated killer cells. Cancer Immunol. Immunother. 38, 317–322 (1994).
    Article CAS Google Scholar
37. Watson, C.A., Camera-Benson, L., Palmer-Crocker, R. & Pober, J.S. ariability among human umbilical vein endothelial cultures. Science 268, 447–448 (1995).
    Article CAS Google Scholar
38. Gullino, P.M. Techniques in tumor pathophysiology. in Methods in Cancer Research (ed. Busch, H.) 45–92 (Academic Press, New York, 1970).
    Google Scholar
39. Melder, R.J., Whiteside, T.L., Vujanovic, N.L., Hiserodt, J.C. & Herberman, R.B. A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells. Cancer Res. 48, 3461–3469 (1988).
    CAS PubMed Google Scholar

Download references